Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 9/20 | 0.61 |
| ▸ | CTSK | P43235 | 8/20 | 0.61 |
| ▸ | CTSB | P07858 | 3/20 | 0.61 |
| ▸ | CTSL | P07711 | 2/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | AKT1 | P31749 | 1/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.51 |
| ▸ | REN | P00797 | 1/20 | 0.50 |
| ▸ | CCKAR | P32238 | 1/20 | 0.49 |
| ▸ | CCKBR | P32239 | 1/20 | 0.49 |
| ▸ | BCL2 | P10415 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7939509 | 0.85 | HDAC4 (0.48) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL7939513 | 0.85 | HDAC4 (0.48) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL3003024 | 0.85 | CTSS (0.57) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL3003020 | 0.85 | CTSS (0.57) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL26436560 | 0.84 | LMNA (0.48) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL9610766 | 0.83 | HDAC8 (0.72) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL3944495 | 0.83 | HDAC8 (0.72) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL23566401 | 0.83 | CTSS (0.57) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL7498242 | 0.83 | CTSS (0.57) | CTSSCTSKCTSBCTSLHDAC8 | |
| SCHEMBL23566403 | 0.83 | CTSS (0.57) | CTSSCTSKCTSBCTSLHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713416-B2 | POROSITY STRUCTURE; WATER IN OIL MICROEMULSION; MIXING SOLVENT AND SURFACTANT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2004-03-30 | — | — | US | disclosed |
| US-6660780-B2 | Material that has been polymerized around molecules of an imprint compound in such a way that when the imprint group is removed from the material, cavities or \"imprinted sites\" remain in the material that are negative images of the imprint | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2003-12-09 | — | — | US | disclosed |
| US-20030191205-A1 | MOLECULARLY-IMPRINTED MATERIAL MADE BY TEMPLATE-DIRECTED SYNTHESIS | MARKOWITZ MICHAEL A (US) | 2003-10-09 | — | — | US | disclosed |
| US-20030139483-A1 | Molecularly-imprinted material made by template-directed synthesis | NAVY, SECRETARY OF THE, THE UNITED STATES OF AMERICA AS, REPRESENTED BY THE | 2003-07-24 | — | — | US | disclosed |
| US-6583191-B2 | Combining surfactant coupled to imprint group with solvent to form a mixture and allowing surfactant to self-assemble; polymerizing monomer to form solid having a surface topography complementary to that of supramolecular structure | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2003-06-24 | — | — | US | disclosed |
| US-20020065334-A1 | Molecularly-imprinted material made by template-directed synthesis | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2002-05-30 | — | — | US | disclosed |
| US-6310110-B1 | COMBINING THE SURFACTANT COUPLED TO AN IMPRINT GROUP, COMBINING SURFACTANT WITH SOLVENT FOR SELF-ASSEMBLING OF SUPERMOLECULAR STRUCTURE, COMBINING IT WITH A REACTIVE MONOMER WHERE SUPERMOLECULE WORK AS TEMPLET FOR ORGNIZING | USA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2001-10-30 | — | — | US | disclosed |
| WO-2001009035-A1 | MOLECULARLY-IMPRINTED MATERIAL MADE BY TEMPLATE-DIRECTED SYNTHESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, ASREPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2001-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139483-A1 | Molecularly-imprinted material made by template-directed synthesis | POLM, SGMS1, MSI2 | CTSS 4115/4885CTSK 4220/4885CTSB 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.